The NeuralGlider Inserter
NeuralGlider Inserter Reduces Tissue Deformation During Trans-pial Insertion of DBS Electrodes in an ex vivo Model
(Left) Without the NeuralGlider Inserter. (Right) With the NeuralGlider Inserter.
Selected Publications
“Direct Mapping of the Nucleus Accumbens Core and Shell using Deep Brain Stimulation with functional Magnetic Resonance Imaging in Rats.” Kim H-J, Clement RS, Bagwell RB, Tirko NN, Shih Y-Y, Lee S-H.
“Influence of Implantation Depth on the Performance of Intracortical Probe Recording Sites.” Usoro JO, Dogra K, Abbott JR, Radhakrishna R, Cogan SF, Pancrazio JJ, Patnaik SS.
About the NeuralGlider Inserter
The NeuralGlider Inserter uses ultrasonic micro-vibration to reduce forces and resultant dimpling during neural implant insertions. Neural implants have been critical tools in neural interfacing studies for decades and are widely available from commercial vendors.
The NeuralGlider Inserter has been tested in vitro, ex vivo, and in vivo with a variety of neural implants. The reduced insertion force facilitates slow (0.1 mm/s), accurate implant insertions while minimizing displacement/dimpling of the cortical surface, helping to preserve the integrity of the underlying neural tissue.
Please review the Operator’s Manual for full indications, contraindications, and cautions.
NeuralGlider User Testimonials
The NeuralGlider Inserter helped us to get a better outcome for our DBS-fMRI study. The micro-vibration really reduced impact resistance during implantation of the flexible probe as well as chronic glial cell formation, so that we could get higher accuracy of electrode
With the NeuralGlider Inserter, we got much more consistent surgical results.
Research Partners
University of Pittsburgh
Carnegie Mellon University
Tulane University
Penn State University
Lawrence Livermore National Laboratory
University of North Carolina at Chapel Hill
Our Distributors
These works are/were partially supported by the Brain Initiative at the National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS) Small Business Innovation Research (SBIR) Grant No. NS105500 and National Institute on Drug Abuse (NIH/NIDA) SBIR Grant No. DA051265 and the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Electrical Prescriptions Contract No. HR0011-16-C-0094. The views, opinions, and/or findings contained in this work are those of Actuated Medical, Inc. and should not be construed as an official government position, policy, or decision unless so designated by other documentation.